The 16 most recent market catalysts affecting $ALHC, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Nov 17, 2026
Corporate Catalyst
Bullish
Impact 95
Armlogi Holding Corp. Reports First Quarter Fiscal 2027 Financial Results
Armlogi Holding Corp. reported a net loss of $4.1 million for Q1 FY27, an improvement from the prior year, but total revenue significantly decreased to $36.9 million from $49.5 mil…
Nov 3, 2026
Corporate Catalyst
Bearish
Impact 75
Alignment Healthcare Faces Analyst Downgrades and Outlook Updates
Alignment Healthcare (ALHC) has faced significant negative analyst sentiment, with KeyBanc downgrading the stock and several firms cutting price targets. This is primarily driven b…
Oct 29, 2026
Corporate Catalyst
Bearish
Impact 85
Alignment Healthcare Reports Third Quarter 2026 Financial Results
Alignment Healthcare announced its Q3 2026 financial results, showing robust revenue growth of 36.7% year-over-year and a 31.2% increase in health plan membership. However, the com…
Oct 12, 2026
Corporate Catalyst
Bearish
Impact 55
UBS Maintains Neutral on Alignment Healthcare, Lowers Price Target to $9
UBS analyst Jonathan Yong has significantly cut the price target for Alignment Healthcare (ALHC) from $22 to $9, while keeping a 'Neutral' rating. This substantial reduction in the…
Oct 9, 2026
Corporate Catalyst
Bearish
Impact 65
JP Morgan Maintains Overweight on Alignment Healthcare, Lowers Price Target to $10
JP Morgan's decision to maintain an 'Overweight' rating on Alignment Healthcare (ALHC) suggests a belief in the company's fundamental strength or long-term potential. However, the …
Oct 9, 2026
Corporate Catalyst
Bearish
Impact 65
Keybanc Maintains Overweight on Alignment Healthcare, Lowers Price Target to $12
Keybanc's decision to maintain an 'Overweight' rating on Alignment Healthcare (ALHC) while drastically cutting its price target from $28 to $12 suggests a complex view. It implies …
Oct 9, 2026
Corporate Catalyst
Bearish
Impact 95
Alignment Healthcare Stock Hit by Bearish Outlook After Costly Medicare Advantage Rating Downgrade
Alignment Healthcare (ALHC) experienced a significant setback with the Centers for Medicare & Medicaid Services' (CMS) 2027 Medicare Advantage Star Ratings. While most of its contr…
Oct 9, 2026
Corporate Catalyst
Bearish
Impact 85
Alignment Healthcare, RenX Enterprises And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
Alignment Healthcare's stock plummeted due to the CMS downgrade of its largest California Medicare Advantage contract. This is a critical event because a 3.5-star rating makes the …
Oct 9, 2026
Corporate Catalyst
Bearish
Impact 85
Alignment Healthcare shares are trading lower after the CMS 2027 Medicare Advantage Part D Release downgraded the company's largest California contract to 3.5 stars, making it ineligible for bonus payments.
This headline represents a significant corporate catalyst for Alignment Healthcare. The downgrade of their largest California Medicare Advantage contract to 3.5 stars means they wi…
Oct 8, 2026
Corporate Catalyst
Bearish
Impact 85
Alignment Healthcare shares are trading lower after the CMS 2027 Medicare Advantage Part D Release downgraded the company's largest California contract to 3.5 stars, making it ineligible for bonus payments.
This headline represents a significant corporate catalyst for Alignment Healthcare. The downgrade of their largest California Medicare Advantage contract to 3.5 stars means they wi…
Aug 4, 2026
Corporate Catalyst
Bearish
Impact 55
JP Morgan Maintains Overweight on Alignment Healthcare, Lowers Price Target to $22
JP Morgan analyst John Stansel maintained an 'Overweight' rating on Alignment Healthcare (ALHC), signaling continued confidence in the company's long-term prospects. However, the p…
Aug 3, 2026
Corporate Catalyst
Bearish
Impact 55
Raymond James Downgrades Alignment Healthcare to Outperform, Lowers Price Target to $19
Raymond James analyst John Ransom downgraded Alignment Healthcare (ALHC) from a 'Strong Buy' to 'Outperform' and simultaneously lowered the price target from $22 to $19. This actio…
Jul 30, 2026
Corporate Catalyst
Bullish
Impact 75
Alignment Healthcare Raises FY2026 Sales Guidance from $5.160B-$5.205B to $5.195B-$5.225B vs $5.189B Est
Alignment Healthcare (ALHC) has raised its FY2026 sales guidance from $5.160 billion-$5.205 billion to $5.195 billion-$5.225 billion. This upward revision is significant as it surp…
Jul 30, 2026
Corporate Catalyst
Bullish
Impact 92
Alignment Healthcare Q2 EPS $0.17 Beats $0.13 Estimate, Sales $1.336B Beat $1.310B Estimate
Alignment Healthcare announced its Q2 earnings, reporting $0.17 per share, which significantly beat the analyst consensus of $0.13. Sales also exceeded expectations at $1.336 billi…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.